Loading…

Epi Evident: Biosurveillance to Monitor, Compare, and Forecast Disease Case Counts

ObjectiveEpi Evident is a web based application built to empower public health analysts by providing a platform that improves monitoring, comparing, and forecasting case counts and period prevalence of notifiable diseases for any scale jurisdiction at regional, country, or global-level. This proof o...

Full description

Saved in:
Bibliographic Details
Published in:Online journal of public health informatics 2018-05, Vol.10 (1)
Main Authors: Tomaszewski, Natalie, Agnihotri, Meeshu, Cheng, Huiwen, Bhadke, Ashutosh, Henry, Michael, Charles, Lauren E.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page
container_title Online journal of public health informatics
container_volume 10
creator Tomaszewski, Natalie
Agnihotri, Meeshu
Cheng, Huiwen
Bhadke, Ashutosh
Henry, Michael
Charles, Lauren E.
description ObjectiveEpi Evident is a web based application built to empower public health analysts by providing a platform that improves monitoring, comparing, and forecasting case counts and period prevalence of notifiable diseases for any scale jurisdiction at regional, country, or global-level. This proof of concept application development addresses improving visualization, access, situational awareness, and prediction of disease behavior.IntroductionThe Epi Evident application was designed for clear and comprehensive visualization for monitoring, comparing, and forecasting notifiable diseases simultaneously across chosen countries. Epi Evident addresses the taxing analytical evaluation of how diseases behave differently across countries. This application provides a user-friendly platform with easily interpretable analytics which allows analysts to conduct biosurveillance with minimal user tasks. Developed at the Pacific Northwest National Laboratory (PNNL), Epi Evident utilizes time-series disease case count data from the Biosurveillance Ecosystem (BSVE) application Epi Archive (1). This diverse data source is filtered through the flexible Epi Evident workflow for forecast model building designed to integrate any entering combination of country and disease. The application aims to quickly inform analysts of anomalies in disease & location specific behavior and aid in evidence based decision making to help control or prevent disease outbreaks.MethodsA workflow was constructed to define the best disease forecast model for each location based on an adjustable method approach. The differences in disease behavior across countries was achieved through a React/Python application with a user-friendly output for monitoring and comparing different combinations.The forecast model building workflow consisted of three major steps to determine the best fit model for a given disease-country pair: data type, model type, and model comparison & selection. Testing various disease-country combinations allowed for direct evaluation of the workflow efficiency, flexibility, and criteria for determining the best fit model. Data type was characterized as either seasonal, cyclic, or sporadic. Depending on data type, a specific time series forecasting model was applied. In general, seasonal or cyclic data required either an Auto-Regression Integrated Moving Average (ARIMA) model or a Seasonal Auto-Regression Integrated Moving Average (SARIMA) model while sporadic datasets employed a Poisso
doi_str_mv 10.5210/ojphi.v10i1.8324
format article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6088072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_6088072</sourcerecordid><originalsourceid>FETCH-LOGICAL-c962-5e66b5dc219a3448d44fd63d5fdcfdc23dee093d6e1f516112df5e2d2a0a4ffc3</originalsourceid><addsrcrecordid>eNpVkNtKAzEQQIMoWLTvPuYDujXXvfgg6NqqUBGk7yFNJjZlu1mSbcG_d9uK6DDMDAxzYA5CN5RMJaPkNmy6tZ_uKfF0WnImztCIVqLImCyq8z_zJRqntCFD8EJSQUfoY9Z5PNt7C21_hx99SLu4B980ujWA-4DfQuv7ECe4DttOR5hg3Vo8DxGMTj1-8gl0AlwfS9i1fbpGF043CcY__Qot57Nl_ZIt3p9f64dFZqqcZRLyfCWtYbTSXIjSCuFszq101gzJuAUgFbc5UCdpTimzTgKzTBMtnDP8Ct2fsN1utQVrhgeiblQX_VbHLxW0V_83rV-rz7BXOSlLUrABQE4AE0NKEdzvLSXqoFUdtaqjVnXQyr8BCBpvRA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Epi Evident: Biosurveillance to Monitor, Compare, and Forecast Disease Case Counts</title><source>PubMed Central</source><creator>Tomaszewski, Natalie ; Agnihotri, Meeshu ; Cheng, Huiwen ; Bhadke, Ashutosh ; Henry, Michael ; Charles, Lauren E.</creator><creatorcontrib>Tomaszewski, Natalie ; Agnihotri, Meeshu ; Cheng, Huiwen ; Bhadke, Ashutosh ; Henry, Michael ; Charles, Lauren E.</creatorcontrib><description>ObjectiveEpi Evident is a web based application built to empower public health analysts by providing a platform that improves monitoring, comparing, and forecasting case counts and period prevalence of notifiable diseases for any scale jurisdiction at regional, country, or global-level. This proof of concept application development addresses improving visualization, access, situational awareness, and prediction of disease behavior.IntroductionThe Epi Evident application was designed for clear and comprehensive visualization for monitoring, comparing, and forecasting notifiable diseases simultaneously across chosen countries. Epi Evident addresses the taxing analytical evaluation of how diseases behave differently across countries. This application provides a user-friendly platform with easily interpretable analytics which allows analysts to conduct biosurveillance with minimal user tasks. Developed at the Pacific Northwest National Laboratory (PNNL), Epi Evident utilizes time-series disease case count data from the Biosurveillance Ecosystem (BSVE) application Epi Archive (1). This diverse data source is filtered through the flexible Epi Evident workflow for forecast model building designed to integrate any entering combination of country and disease. The application aims to quickly inform analysts of anomalies in disease &amp; location specific behavior and aid in evidence based decision making to help control or prevent disease outbreaks.MethodsA workflow was constructed to define the best disease forecast model for each location based on an adjustable method approach. The differences in disease behavior across countries was achieved through a React/Python application with a user-friendly output for monitoring and comparing different combinations.The forecast model building workflow consisted of three major steps to determine the best fit model for a given disease-country pair: data type, model type, and model comparison &amp; selection. Testing various disease-country combinations allowed for direct evaluation of the workflow efficiency, flexibility, and criteria for determining the best fit model. Data type was characterized as either seasonal, cyclic, or sporadic. Depending on data type, a specific time series forecasting model was applied. In general, seasonal or cyclic data required either an Auto-Regression Integrated Moving Average (ARIMA) model or a Seasonal Auto-Regression Integrated Moving Average (SARIMA) model while sporadic datasets employed a Poisson model. Several model candidates for a single country and disease combination were then compared to determine which was the best fit model. ARIMA and SARIMA model selection criteria included their respective order significance, residual diagnostics, and lowest possible combination of Akaike Information Criterion and Root Mean Square Error (RMSE) values. Poisson model selection criteria involved Poisson or negative binomial distribution and event probability, lag dependency of immediate past events or seasonality, and lowest possible RMSE. To enhance the user’s monitoring and comparisons across multiple countries and diseases, each forecasted case counts supplied a corresponding period prevalence. This period prevalence was calculated by dividing the case counts by the population in the selected country and timeframe. Population records were obtained through the public World Health Organization database (2).ResultsA variety of visualization tools on Epi Evident allows convenient interpretation on behaviors of diseases spanning multiple countries simultaneously (Figure 1). Countries, diseases, and timeframe are selected and displayed within a matrix alongside with their corresponding forecasts for case counts and period prevalence. By providing this full representation, users can easily interpret and anticipate disease behavior while monitoring, comparing, and forecasting case counts and period prevalence across multiple countries. For future work, the Epi Evident workflow can be scaled to accommodate any disease-country combination with automated model selection to allow easier and more efficient biosurveillance.ConclusionsEpi Evident empowers analysts to visualize, monitor, compare, and forecast disease case counts and period prevalence across countries. Epi Evident exemplifies how filtering diverse data through a flexible workflow can be scalable to output distinctive models for any given country and disease combination. Thus, providing accurate forecasting and enhanced situational awareness throughout the globe. Implementing this application’s methodology helps enhance and expand biosurveillance efficacy for multiple diseases across multiple countries simultaneously.References1. Generous Nicholas, Fairchild Geoffrey, Khalsa Hari, Tasseff Byron, Arnold James. Epi Archive: An automated data collection of notifiable disease data. Online Journal of Public Health Informatics. 2017. 9(1):e372. http://apps.who.int/gho/data/view.main.POP2040?lang=en Accessed: 6/20/2017</description><identifier>ISSN: 1947-2579</identifier><identifier>EISSN: 1947-2579</identifier><identifier>DOI: 10.5210/ojphi.v10i1.8324</identifier><language>eng</language><publisher>University of Illinois at Chicago Library</publisher><subject>ISDS 2018 Conference Abstracts</subject><ispartof>Online journal of public health informatics, 2018-05, Vol.10 (1)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088072/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088072/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Tomaszewski, Natalie</creatorcontrib><creatorcontrib>Agnihotri, Meeshu</creatorcontrib><creatorcontrib>Cheng, Huiwen</creatorcontrib><creatorcontrib>Bhadke, Ashutosh</creatorcontrib><creatorcontrib>Henry, Michael</creatorcontrib><creatorcontrib>Charles, Lauren E.</creatorcontrib><title>Epi Evident: Biosurveillance to Monitor, Compare, and Forecast Disease Case Counts</title><title>Online journal of public health informatics</title><description>ObjectiveEpi Evident is a web based application built to empower public health analysts by providing a platform that improves monitoring, comparing, and forecasting case counts and period prevalence of notifiable diseases for any scale jurisdiction at regional, country, or global-level. This proof of concept application development addresses improving visualization, access, situational awareness, and prediction of disease behavior.IntroductionThe Epi Evident application was designed for clear and comprehensive visualization for monitoring, comparing, and forecasting notifiable diseases simultaneously across chosen countries. Epi Evident addresses the taxing analytical evaluation of how diseases behave differently across countries. This application provides a user-friendly platform with easily interpretable analytics which allows analysts to conduct biosurveillance with minimal user tasks. Developed at the Pacific Northwest National Laboratory (PNNL), Epi Evident utilizes time-series disease case count data from the Biosurveillance Ecosystem (BSVE) application Epi Archive (1). This diverse data source is filtered through the flexible Epi Evident workflow for forecast model building designed to integrate any entering combination of country and disease. The application aims to quickly inform analysts of anomalies in disease &amp; location specific behavior and aid in evidence based decision making to help control or prevent disease outbreaks.MethodsA workflow was constructed to define the best disease forecast model for each location based on an adjustable method approach. The differences in disease behavior across countries was achieved through a React/Python application with a user-friendly output for monitoring and comparing different combinations.The forecast model building workflow consisted of three major steps to determine the best fit model for a given disease-country pair: data type, model type, and model comparison &amp; selection. Testing various disease-country combinations allowed for direct evaluation of the workflow efficiency, flexibility, and criteria for determining the best fit model. Data type was characterized as either seasonal, cyclic, or sporadic. Depending on data type, a specific time series forecasting model was applied. In general, seasonal or cyclic data required either an Auto-Regression Integrated Moving Average (ARIMA) model or a Seasonal Auto-Regression Integrated Moving Average (SARIMA) model while sporadic datasets employed a Poisson model. Several model candidates for a single country and disease combination were then compared to determine which was the best fit model. ARIMA and SARIMA model selection criteria included their respective order significance, residual diagnostics, and lowest possible combination of Akaike Information Criterion and Root Mean Square Error (RMSE) values. Poisson model selection criteria involved Poisson or negative binomial distribution and event probability, lag dependency of immediate past events or seasonality, and lowest possible RMSE. To enhance the user’s monitoring and comparisons across multiple countries and diseases, each forecasted case counts supplied a corresponding period prevalence. This period prevalence was calculated by dividing the case counts by the population in the selected country and timeframe. Population records were obtained through the public World Health Organization database (2).ResultsA variety of visualization tools on Epi Evident allows convenient interpretation on behaviors of diseases spanning multiple countries simultaneously (Figure 1). Countries, diseases, and timeframe are selected and displayed within a matrix alongside with their corresponding forecasts for case counts and period prevalence. By providing this full representation, users can easily interpret and anticipate disease behavior while monitoring, comparing, and forecasting case counts and period prevalence across multiple countries. For future work, the Epi Evident workflow can be scaled to accommodate any disease-country combination with automated model selection to allow easier and more efficient biosurveillance.ConclusionsEpi Evident empowers analysts to visualize, monitor, compare, and forecast disease case counts and period prevalence across countries. Epi Evident exemplifies how filtering diverse data through a flexible workflow can be scalable to output distinctive models for any given country and disease combination. Thus, providing accurate forecasting and enhanced situational awareness throughout the globe. Implementing this application’s methodology helps enhance and expand biosurveillance efficacy for multiple diseases across multiple countries simultaneously.References1. Generous Nicholas, Fairchild Geoffrey, Khalsa Hari, Tasseff Byron, Arnold James. Epi Archive: An automated data collection of notifiable disease data. Online Journal of Public Health Informatics. 2017. 9(1):e372. http://apps.who.int/gho/data/view.main.POP2040?lang=en Accessed: 6/20/2017</description><subject>ISDS 2018 Conference Abstracts</subject><issn>1947-2579</issn><issn>1947-2579</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkNtKAzEQQIMoWLTvPuYDujXXvfgg6NqqUBGk7yFNJjZlu1mSbcG_d9uK6DDMDAxzYA5CN5RMJaPkNmy6tZ_uKfF0WnImztCIVqLImCyq8z_zJRqntCFD8EJSQUfoY9Z5PNt7C21_hx99SLu4B980ujWA-4DfQuv7ECe4DttOR5hg3Vo8DxGMTj1-8gl0AlwfS9i1fbpGF043CcY__Qot57Nl_ZIt3p9f64dFZqqcZRLyfCWtYbTSXIjSCuFszq101gzJuAUgFbc5UCdpTimzTgKzTBMtnDP8Ct2fsN1utQVrhgeiblQX_VbHLxW0V_83rV-rz7BXOSlLUrABQE4AE0NKEdzvLSXqoFUdtaqjVnXQyr8BCBpvRA</recordid><startdate>20180530</startdate><enddate>20180530</enddate><creator>Tomaszewski, Natalie</creator><creator>Agnihotri, Meeshu</creator><creator>Cheng, Huiwen</creator><creator>Bhadke, Ashutosh</creator><creator>Henry, Michael</creator><creator>Charles, Lauren E.</creator><general>University of Illinois at Chicago Library</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20180530</creationdate><title>Epi Evident: Biosurveillance to Monitor, Compare, and Forecast Disease Case Counts</title><author>Tomaszewski, Natalie ; Agnihotri, Meeshu ; Cheng, Huiwen ; Bhadke, Ashutosh ; Henry, Michael ; Charles, Lauren E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c962-5e66b5dc219a3448d44fd63d5fdcfdc23dee093d6e1f516112df5e2d2a0a4ffc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>ISDS 2018 Conference Abstracts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tomaszewski, Natalie</creatorcontrib><creatorcontrib>Agnihotri, Meeshu</creatorcontrib><creatorcontrib>Cheng, Huiwen</creatorcontrib><creatorcontrib>Bhadke, Ashutosh</creatorcontrib><creatorcontrib>Henry, Michael</creatorcontrib><creatorcontrib>Charles, Lauren E.</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Online journal of public health informatics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tomaszewski, Natalie</au><au>Agnihotri, Meeshu</au><au>Cheng, Huiwen</au><au>Bhadke, Ashutosh</au><au>Henry, Michael</au><au>Charles, Lauren E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epi Evident: Biosurveillance to Monitor, Compare, and Forecast Disease Case Counts</atitle><jtitle>Online journal of public health informatics</jtitle><date>2018-05-30</date><risdate>2018</risdate><volume>10</volume><issue>1</issue><issn>1947-2579</issn><eissn>1947-2579</eissn><abstract>ObjectiveEpi Evident is a web based application built to empower public health analysts by providing a platform that improves monitoring, comparing, and forecasting case counts and period prevalence of notifiable diseases for any scale jurisdiction at regional, country, or global-level. This proof of concept application development addresses improving visualization, access, situational awareness, and prediction of disease behavior.IntroductionThe Epi Evident application was designed for clear and comprehensive visualization for monitoring, comparing, and forecasting notifiable diseases simultaneously across chosen countries. Epi Evident addresses the taxing analytical evaluation of how diseases behave differently across countries. This application provides a user-friendly platform with easily interpretable analytics which allows analysts to conduct biosurveillance with minimal user tasks. Developed at the Pacific Northwest National Laboratory (PNNL), Epi Evident utilizes time-series disease case count data from the Biosurveillance Ecosystem (BSVE) application Epi Archive (1). This diverse data source is filtered through the flexible Epi Evident workflow for forecast model building designed to integrate any entering combination of country and disease. The application aims to quickly inform analysts of anomalies in disease &amp; location specific behavior and aid in evidence based decision making to help control or prevent disease outbreaks.MethodsA workflow was constructed to define the best disease forecast model for each location based on an adjustable method approach. The differences in disease behavior across countries was achieved through a React/Python application with a user-friendly output for monitoring and comparing different combinations.The forecast model building workflow consisted of three major steps to determine the best fit model for a given disease-country pair: data type, model type, and model comparison &amp; selection. Testing various disease-country combinations allowed for direct evaluation of the workflow efficiency, flexibility, and criteria for determining the best fit model. Data type was characterized as either seasonal, cyclic, or sporadic. Depending on data type, a specific time series forecasting model was applied. In general, seasonal or cyclic data required either an Auto-Regression Integrated Moving Average (ARIMA) model or a Seasonal Auto-Regression Integrated Moving Average (SARIMA) model while sporadic datasets employed a Poisson model. Several model candidates for a single country and disease combination were then compared to determine which was the best fit model. ARIMA and SARIMA model selection criteria included their respective order significance, residual diagnostics, and lowest possible combination of Akaike Information Criterion and Root Mean Square Error (RMSE) values. Poisson model selection criteria involved Poisson or negative binomial distribution and event probability, lag dependency of immediate past events or seasonality, and lowest possible RMSE. To enhance the user’s monitoring and comparisons across multiple countries and diseases, each forecasted case counts supplied a corresponding period prevalence. This period prevalence was calculated by dividing the case counts by the population in the selected country and timeframe. Population records were obtained through the public World Health Organization database (2).ResultsA variety of visualization tools on Epi Evident allows convenient interpretation on behaviors of diseases spanning multiple countries simultaneously (Figure 1). Countries, diseases, and timeframe are selected and displayed within a matrix alongside with their corresponding forecasts for case counts and period prevalence. By providing this full representation, users can easily interpret and anticipate disease behavior while monitoring, comparing, and forecasting case counts and period prevalence across multiple countries. For future work, the Epi Evident workflow can be scaled to accommodate any disease-country combination with automated model selection to allow easier and more efficient biosurveillance.ConclusionsEpi Evident empowers analysts to visualize, monitor, compare, and forecast disease case counts and period prevalence across countries. Epi Evident exemplifies how filtering diverse data through a flexible workflow can be scalable to output distinctive models for any given country and disease combination. Thus, providing accurate forecasting and enhanced situational awareness throughout the globe. Implementing this application’s methodology helps enhance and expand biosurveillance efficacy for multiple diseases across multiple countries simultaneously.References1. Generous Nicholas, Fairchild Geoffrey, Khalsa Hari, Tasseff Byron, Arnold James. Epi Archive: An automated data collection of notifiable disease data. Online Journal of Public Health Informatics. 2017. 9(1):e372. http://apps.who.int/gho/data/view.main.POP2040?lang=en Accessed: 6/20/2017</abstract><pub>University of Illinois at Chicago Library</pub><doi>10.5210/ojphi.v10i1.8324</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1947-2579
ispartof Online journal of public health informatics, 2018-05, Vol.10 (1)
issn 1947-2579
1947-2579
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6088072
source PubMed Central
subjects ISDS 2018 Conference Abstracts
title Epi Evident: Biosurveillance to Monitor, Compare, and Forecast Disease Case Counts
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A11%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epi%20Evident:%20Biosurveillance%20to%20Monitor,%20Compare,%20and%20Forecast%20Disease%20Case%20Counts&rft.jtitle=Online%20journal%20of%20public%20health%20informatics&rft.au=Tomaszewski,%20Natalie&rft.date=2018-05-30&rft.volume=10&rft.issue=1&rft.issn=1947-2579&rft.eissn=1947-2579&rft_id=info:doi/10.5210/ojphi.v10i1.8324&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_6088072%3C/pubmedcentral_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c962-5e66b5dc219a3448d44fd63d5fdcfdc23dee093d6e1f516112df5e2d2a0a4ffc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true